Menu Expand
Bipolar Depression, An Issue of Psychiatric Clinics of North America, E-Book

Bipolar Depression, An Issue of Psychiatric Clinics of North America, E-Book

John L. Beyer

(2016)

Additional Information

Book Details

Abstract

This issue of the Psychiatric Clinics edited by Dr. John Beyer is dedicated to the topic of Bipolar Depression, from the genetics of the disorder, to the therapeutic options, to treatment in special populations. Articles in this issue include, but are not limited to: Differences in Bipolar and Unipolar Depression, Suicide and Bipolar Disorder, Social Relationships, Support, and Life Events in Bipolar Disorder, Treatment of Bipolar Depression in Pregnancy and the Post-Partum Period, Psychotherapy for Bipolar Depression, Cognition, Dementia, and Bipolar Depression, and Genetics of Bipolar Disorder.

Table of Contents

Section Title Page Action Price
Front Cover Cover
Bipolar Depression\r i
Copyright\r ii
Contributors iii
EDITOR iii
AUTHORS iii
Contents vii
Preface: The Challenge of Bipolar Depression in the 21st Century \r vii
Discriminating Between Bipolar Disorder and Major Depressive Disorder\r vii
Treatment of Bipolar Depression: Evolving Recommendations\r vii
Psychotherapeutic Treatment of Bipolar Depression\r vii
Bipolar Depression: Pregnancy, Postpartum, and Lactation\r viii
Nutrition and Bipolar Depression\r viii
The Influence of Trauma, Life Events, and Social Relationships on Bipolar Depression\r viii
Bipolar Depression and Cognitive Impairment: Shared Mechanisms and New Treatment Avenues\r viii
Suicide Behaviors in Bipolar Disorder: A Review and Update for the Clinician\r ix
Bipolar Disorder and Inflammation\r ix
Genetics of Bipolar Disorder: Recent Update and Future Directions\r ix
PSYCHIATRIC CLINICS OF\rNORTH AMERICA\r x
FORTHCOMING ISSUES x
June 2016 x
September 2016 x
December 2016 x
RECENT ISSUES x
December 2015 x
September 2015 x
June 2015 x
Preface: The Challenge of Bipolar Depression in the 21st Century \r xi
REFERENCE xii
Discriminating Between Bipolar Disorder and Major Depressive Disorder 1
Key points 1
MOTIVATION FOR DISCRIMINATING BIPOLAR DISORDER FROM MAJOR DEPRESSIVE DISORDER 2
Absence of Antidepressant Efficacy 2
Risk for Antidepressant-Associated Mania 3
PREVALENCE AND CONTRIBUTORS TO MISDIAGNOSIS 3
STRATEGIES FOR IMPROVING DIAGNOSIS 4
BIOMARKERS AND BIOLOGY 5
LIMITATIONS AND NEXT STEPS 6
ACKNOWLEDGMENTS 7
REFERENCES 7
Treatment of Bipolar Depression 11
Key points 11
INTRODUCTION 11
MOVING AWAY FROM ANTIDEPRESSANT AUGMENTATION OF MOOD STABILIZERS AS FIRST-LINE TREATMENT 13
CURRENT FIRST-LINE OPTIONS FOR TREATMENT OF BIPOLAR DEPRESSION 15
MOOD STABILIZERS IN THE PROPHYLACTIC TREATMENT OF BIPOLAR DEPRESSION 17
Lithium 17
Carbamazepine 17
Lamotrigine 17
Valproate 18
SOME BUT NOT ALL ATYPICAL ANTIPSYCHOTICS ARE EFFECTIVE IN BIPOLAR DEPRESSION PREVENTION 18
ADJUNCTIVE OFF-LABEL TREATMENT APPROACHES FOR BIPOLAR DEPRESSION 19
TREATMENT OF SPECIAL POPULATIONS 22
Ultra Rapid and Ultradian Cycling 22
Anxiety Disorder Comorbidity 23
Substance Abuse Comorbidity 24
Childhood-Onset Bipolar Depression 24
Medical Comorbidities 26
Cognitive Dysfunction 27
SUMMARY OF PRINCIPLES OF COMPLEX COMBINATION THERAPY 27
REFERENCES 30
Psychotherapeutic Treatment of Bipolar Depression 35
Key points 35
OVERVIEW 36
ASSESSMENT OF BIPOLAR DEPRESSION 36
COGNITIVE BEHAVIORAL THERAPIES 38
FAMILY FOCUSED THERAPY 40
INTERPERSONAL AND SOCIAL RHYTHM THERAPY 41
MINDFULNESS-BASED COGNITIVE THERAPY 42
DIALECTICAL BEHAVIOR THERAPY 44
COMMON PRINCIPLES FOR EFFECTIVE TREATMENT 45
FUTURE MODELS 46
Behavioral Activation 47
Cognitive Behavioral Analysis System of Psychotherapy 48
Unified Protocol 48
SUMMARY 48
REFERENCES 48
Bipolar Depression 57
Key points 57
INTRODUCTION 57
EPIDEMIOLOGY 58
Bipolar Rates in Women 58
Bipolar Rates During Pregnancy and the Postpartum Period 58
Rates of Relapse with Sudden Stopping of Medications 59
Risks to Fetus and Neonate with Untreated Maternal Diagnoses of Bipolar Disorder 59
MEDICATIONS 59
Explanation of the Food and Drug Administration Rating System for Medication Effects in Pregnancy 59
Discussion of Specific Medications and Risks 62
Pharmacokinetic changes in pregnancy 62
Lamotrigine 63
Nutrition and Bipolar Depression 75
Key points 75
INTRODUCTION 75
NUTRITION IN BIPOLAR DISORDER 76
THEORETIC FRAMEWORK FOR INTERACTION BETWEEN NUTRITION AND BIPOLAR DISORDER 77
Monoaminergic Activity 78
Inflammatory Processes 78
Neuroplasticity and Neuroprogression 78
Oxidative Stress 79
BIPOLAR DEPRESSION AND NUTRITIONAL SUPPLEMENTS 79
Omega-3 Fatty Acids 79
N-acetylcysteine 80
Vitamins 81
SUMMARY 82
REFERENCES 82
The Influence of Trauma, Life Events, and Social Relationships on Bipolar Depression 87
Key points 87
EARLY ADVERSITY AND TRAUMA 88
NEGATIVE LIFE EVENTS DURING ADULTHOOD 89
LOW SOCIAL SUPPORT 90
Family Functioning 90
SUMMARY 90
REFERENCES 91
Bipolar Depression and Cognitive Impairment 95
Key points 95
INTRODUCTION 95
PREVALENCE AND DISTRIBUTION OF COGNITIVE IMPAIRMENTS IN EUTHYMIC PATIENTS 96
COMPARISON OF COGNITIVE DEFICITS IN BIPOLAR DISORDER WITH THOSE IN OTHER PSYCHIATRIC ILLNESSES 96
STUDIES OF THE SHORTER-TERM EFFECT OF BIPOLAR DEPRESSION ON COGNITIVE FUNCTION 96
STUDIES OF THE LONG-TERM EFFECT OF BIPOLAR DEPRESSION ON COGNITIVE FUNCTION 97
IMPACT OF COGNITIVE IMPAIRMENT AND DEPRESSION ON PSYCHOSOCIAL FUNCTIONING 97
POTENTIAL PATHWAYS BETWEEN DEPRESSION AND COGNITIVE IMPAIRMENT 98
Evidence for a Direct Pathway from Bipolar Depression to Cognitive Impairment 99
Evidence for an Indirect Pathway from Bipolar Depression to Health Risks to Cognitive Impairment 100
Obesity 100
Physical Activity 100
Substance Use 101
Sleep 101
Psychosocial Disabilities May Reciprocally Increase Depression and Cognitive Impairment 101
INTERVENTIONS TO REMEDIATE COGNITIVE IMPAIRMENT IN BIPOLAR DEPRESSION 102
Pharmacologic Treatments 102
Cognitive Training and Remediation 103
Physical Activity and Weight Loss Interventions 103
Treatment of Insomnia 104
Compensating for Cognitive Impairment in Learning-Based Therapies 104
SUMMARY 104
REFERENCES 104
Suicide Behaviors in Bipolar Disorder 111
Key points 111
INTRODUCTION 111
SUICIDE BEHAVIORS IN BIPOLAR DISORDER 112
When Researchers Discuss “Suicide Behaviors,” to What Are They Referring? 112
Suicidal act 112
Suicidal ideation 112
Suicide attempt 112
Interrupted attempt 112
Aborted attempt 112
What Is the Prevalence of Suicide Behaviors in Bipolar Disorder? 112
Why Do Patients with Bipolar Disorder Attempt or Commit Suicide? 113
RISK FACTORS FOR SUICIDE BEHAVIORS AND BIPOLAR DISORDER 113
What Then Are the Major Risk Factors in Suicide Behaviors? 113
SOCIODEMOGRAPHIC FACTORS 114
Family History of Completed Suicide 114
Quality of Life/Stressful Life Events 114
Gender 114
Age of Onset 115
Comorbidity 115
Hopelessness 115
Altitude 115
BIPOLAR-SPECIFIC RISK FACTORS 116
Depression 116
Severity of Illness 116
Polarity of First Episode 116
Rapid Cycling 116
BIPOLAR DISORDER, SUICIDE, AND MEDICATIONS 116
Do Antidepressants Increase the Risk of Suicide? 116
Are Anticonvulsants Associated with Increased Suicidal Behaviors? 117
Is Lithium a Suicide-Protective Medication? 117
NEUROBIOLOGY OF SUICIDE AND SUICIDE BEHAVIORS 118
If Medications May Influence Suicide Behaviors, Does This Mean That There Is a Neurobiolgic Mechanism Associated with Suicide? 118
PSYCHOTHERAPY AND SUICIDE IN BIPOLAR DISORDER 118
What About Psychotherapy? 118
SUMMARY 118
REFERENCES 119
Bipolar Disorder and Inflammation 125
Key points 125
INTRODUCTION 125
METHODS 126
RESULTS 126
Bipolar Disorder, Inflammation, and Medical Comorbidity 126
Bipolar Disorder and Cytokine Levels 127
Cytokine Levels and Cognitive Dysfunction in Bipolar Disorder 129
Proposed Pathophysiologic Mechanism 129
Therapeutic Implications 130
SUMMARY 132
REFERENCES 132
Genetics of Bipolar Disorder 139
Key points 139
INTRODUCTION 139
FAMILY STUDIES: MEASURING HERITABILITY FROM THE TOP DOWN 140
MOLECULAR STUDIES: MEASURING HERITABILITY FROM THE BOTTOM UP 141
ASSOCIATION STUDIES: SUCCESS OF GENOME-WIDE APPROACHES AT SCALE 141
FROM GENOME-WIDE ASSOCIATION STUDIES TO FUNCTION: ELUCIDATING MECHANISM 142
Polygenic Risk Scores 144
Rare Variants: The Next Frontier 145
Copy Number Variants 145
Next-Generation Sequencing 146
Genetic Architecture of Bipolar Disease 147
Blurring of Diagnostic Boundaries: Cross-Disorder Associations 149
Pharmacogenetics 149
Toward Personalized Medicine 150
SUMMARY 151
ACKNOWLEDGMENTS 151
REFERENCES 151
Index 157